1. Home
  2. NRXP vs LITB Comparison

NRXP vs LITB Comparison

Compare NRXP & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LITB
  • Stock Information
  • Founded
  • NRXP 2015
  • LITB 2007
  • Country
  • NRXP United States
  • LITB Singapore
  • Employees
  • NRXP N/A
  • LITB N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • NRXP Health Care
  • LITB Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • LITB Nasdaq
  • Market Cap
  • NRXP 32.6M
  • LITB 32.7M
  • IPO Year
  • NRXP N/A
  • LITB N/A
  • Fundamental
  • Price
  • NRXP $2.93
  • LITB $1.23
  • Analyst Decision
  • NRXP Strong Buy
  • LITB
  • Analyst Count
  • NRXP 4
  • LITB 0
  • Target Price
  • NRXP $28.50
  • LITB N/A
  • AVG Volume (30 Days)
  • NRXP 378.9K
  • LITB 11.6K
  • Earning Date
  • NRXP 05-15-2025
  • LITB 05-13-2025
  • Dividend Yield
  • NRXP N/A
  • LITB N/A
  • EPS Growth
  • NRXP N/A
  • LITB N/A
  • EPS
  • NRXP N/A
  • LITB 0.08
  • Revenue
  • NRXP N/A
  • LITB $231,136,000.00
  • Revenue This Year
  • NRXP N/A
  • LITB N/A
  • Revenue Next Year
  • NRXP N/A
  • LITB N/A
  • P/E Ratio
  • NRXP N/A
  • LITB $14.74
  • Revenue Growth
  • NRXP N/A
  • LITB N/A
  • 52 Week Low
  • NRXP $1.10
  • LITB $0.91
  • 52 Week High
  • NRXP $6.01
  • LITB $6.00
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.47
  • LITB 48.38
  • Support Level
  • NRXP $2.55
  • LITB $1.15
  • Resistance Level
  • NRXP $2.72
  • LITB $1.43
  • Average True Range (ATR)
  • NRXP 0.24
  • LITB 0.11
  • MACD
  • NRXP 0.02
  • LITB 0.01
  • Stochastic Oscillator
  • NRXP 80.00
  • LITB 40.54

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: